Literature DB >> 25148023

GATA-3 function in innate and adaptive immunity.

Irma Tindemans1, Nicolas Serafini2, James P Di Santo2, Rudi W Hendriks3.   

Abstract

The zinc-finger transcription factor GATA-3 has received much attention as a master regulator of T helper 2 (Th2) cell differentiation, during which it controls interleukin-4 (IL-4), IL-5, and IL-13 expression. More recently, GATA-3 was shown to contribute to type 2 immunity through regulation of group 2 innate lymphoid cell (ILC2) development and function. Furthermore, during thymopoiesis, GATA-3 represses B cell potential in early T cell precursors, activates TCR signaling in pre-T cells, and promotes the CD4(+) T cell lineage after positive selection. GATA-3 also functions outside the thymus in hematopoietic stem cells, regulatory T cells, CD8(+) T cells, thymic natural killer cells, and ILC precursors. Here we discuss the varied functions of GATA-3 in innate and adaptive immune cells, with emphasis on its activity in T cells and ILCs, and examine the mechanistic basis for the dose-dependent, developmental-stage- and cell-lineage-specific activity of this transcription factor.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25148023     DOI: 10.1016/j.immuni.2014.06.006

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  96 in total

Review 1.  Cytokines, Transcription Factors, and the Initiation of T-Cell Development.

Authors:  Hiroyuki Hosokawa; Ellen V Rothenberg
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-05-01       Impact factor: 10.005

2.  Soluble epoxide hydrolase inhibitor promotes immunomodulation to inhibit bone resorption.

Authors:  M H Napimoga; E P Rocha; C A Trindade-da-Silva; A P D Demasi; E F Martinez; C G Macedo; H B Abdalla; A Bettaieb; F G Haj; J T Clemente-Napimoga; B Inceoglu; B D Hammock
Journal:  J Periodontal Res       Date:  2018-05-31       Impact factor: 4.419

Review 3.  Evolution of myeloid leukemia in children with Down syndrome.

Authors:  Satoshi Saida
Journal:  Int J Hematol       Date:  2016-02-24       Impact factor: 2.490

4.  IL-6 Trans-Signaling Drives Murine Crescentic GN.

Authors:  Gerald S Braun; Yoshikuni Nagayama; Yuichi Maruta; Felix Heymann; Claudia R van Roeyen; Barbara M Klinkhammer; Peter Boor; Luigi Villa; David J Salant; Ute Raffetseder; Stefan Rose-John; Tammo Ostendorf; Jürgen Floege
Journal:  J Am Soc Nephrol       Date:  2015-06-03       Impact factor: 10.121

5.  TOX sets the stage for innate lymphoid cells.

Authors:  Hergen Spits
Journal:  Nat Immunol       Date:  2015-06       Impact factor: 25.606

Review 6.  Transcriptional regulation of innate lymphoid cell fate.

Authors:  Nicolas Serafini; Christian A J Vosshenrich; James P Di Santo
Journal:  Nat Rev Immunol       Date:  2015-06-12       Impact factor: 53.106

Review 7.  Review of Environmental Impact on the Epigenetic Regulation of Atopic Diseases.

Authors:  Saman Sabounchi; Jenna Bollyky; Kari Nadeau
Journal:  Curr Allergy Asthma Rep       Date:  2015-06       Impact factor: 4.806

8.  Transforming Growth Factor-β Signaling Guides the Differentiation of Innate Lymphoid Cells in Salivary Glands.

Authors:  Victor S Cortez; Luisa Cervantes-Barragan; Michelle L Robinette; Jennifer K Bando; Yaming Wang; Theresa L Geiger; Susan Gilfillan; Anja Fuchs; Eric Vivier; Joe C Sun; Marina Cella; Marco Colonna
Journal:  Immunity       Date:  2016-05-03       Impact factor: 31.745

Review 9.  Immunity by equilibrium.

Authors:  Gérard Eberl
Journal:  Nat Rev Immunol       Date:  2016-07-11       Impact factor: 53.106

10.  Monocyte chemotactic protein-induced protein 1 controls allergic airway inflammation by suppressing IL-5-producing TH2 cells through the Notch/Gata3 pathway.

Authors:  Hui Peng; Huan Ning; Qinghong Wang; Wenbao Lu; Yingzi Chang; Tony T Wang; Jinping Lai; Pappachan E Kolattukudy; Rong Hou; Daniel F Hoft; Mark S Dykewicz; Jianguo Liu
Journal:  J Allergy Clin Immunol       Date:  2017-10-27       Impact factor: 10.793

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.